211 related articles for article (PubMed ID: 29264647)
1. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study.
Choe SA; Kim MJ; Lee HJ; Kim J; Chang EM; Kim JW; Park HM; Lyu SW; Lee WS; Yoon TK; Kim YS
Arch Gynecol Obstet; 2018 Mar; 297(3):791-796. PubMed ID: 29264647
[TBL] [Abstract][Full Text] [Related]
2. Effects of growth hormone plus gonadotropins on controlled ovarian stimulation in infertile women of advanced age, poor responders, and previous in vitro fertilization failure patients.
Ho YK; Lee TH; Lee CI; Cheng EH; Huang CC; Huang LS; Lee MS
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):806-810. PubMed ID: 29241924
[TBL] [Abstract][Full Text] [Related]
3. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
Li XL; Wang L; Lv F; Huang XM; Wang LP; Pan Y; Zhang XM
Medicine (Baltimore); 2017 Mar; 96(12):e6443. PubMed ID: 28328856
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis.
Cozzolino M; Cecchino GN; Troiano G; Romanelli C
Fertil Steril; 2020 Jul; 114(1):97-109. PubMed ID: 32553470
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF/ICSI for poor responders; randomized controlled trial.
Mohammad EH; Abou El Serour AG; Mohamed EAH; Abbasy AH; Zaatar M; Rageh KA; Shafeek MM; Issak ER
Taiwan J Obstet Gynecol; 2021 Jan; 60(1):51-55. PubMed ID: 33495008
[TBL] [Abstract][Full Text] [Related]
7. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
8. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
9. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
10. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
12. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone co-treatment on controlled ovarian stimulation in normal ovarian response women can improve embryo quality.
Liu X; Bai H; Xie J; Shi J
Gynecol Endocrinol; 2019 Sep; 35(9):787-791. PubMed ID: 30907187
[TBL] [Abstract][Full Text] [Related]
14. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
15. Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response.
Bayoumi YA; Dakhly DM; Bassiouny YA; Hashish NM
Int J Gynaecol Obstet; 2015 Dec; 131(3):305-8. PubMed ID: 26381201
[TBL] [Abstract][Full Text] [Related]
16. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
17. Growth Hormone Supplementation in the Luteal Phase Before Microdose GnRH Agonist Flare Protocol for In Vitro Fertilization.
Dunne C; Seethram K; Roberts J
J Obstet Gynaecol Can; 2015 Sep; 37(9):810-815. PubMed ID: 26605451
[TBL] [Abstract][Full Text] [Related]
18. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of
Chen Y; Tao L; Lin Y; Li X; Ma C
Gynecol Endocrinol; 2020 Nov; 36(11):955-958. PubMed ID: 32172647
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.
Eftekhar M; Aflatoonian A; Mohammadian F; Eftekhar T
Arch Gynecol Obstet; 2013 May; 287(5):1017-21. PubMed ID: 23208461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
